26 results
8-K
EX-99.1
BTAX
Biostax Corp.
14 Nov 23
Biostax Announces a Director Appointment of Influential Business Leader Craig Suro
4:22pm
“Craig” Suro.
Renowned Virginia native, Mr. Suro, has emerged as a driving force in the realms of business innovation, public policy, and community … are thrilled to have Craig join our team. His remarkable track record in driving capital, innovation, and funding for transformative projects is unparalleled
8-K
EX-99.1
BTAX
Biostax Corp.
2 Nov 23
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
9:00am
as a testament to her unwavering commitment to excellence, innovation, and impactful contributions to both the sports and not-for-profit sectors.
About
8-K
EX-99.1
BTAX
Biostax Corp.
24 Oct 23
Amendments to Articles of Incorporation or Bylaws
9:00am
the company aims to position itself at the forefront of innovation in the field, aiming to improve health outcomes for those affected by HIV.
Commenting
8-K
us2vwxk310riukemxeym
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
8-K
gnf0l
3 Jun 22
Departure of Directors or Certain Officers
4:57pm
8-K
EX-99.1
c6y o1mtbjklnn9u7n4
3 Jun 22
Departure of Directors or Certain Officers
4:57pm
8-K
EX-99.1
gom0t5785hdn90k7i4ya
16 Apr 20
Immune Therapeutics, Inc. and Forte Biotechnology Intl Corp Sign Sub-Licensing Agreement for Animal Health Applications
4:12pm
DRS/A
7snxya 5z
14 Oct 16
Draft registration statement (amended)
12:00am
S-1
wvbbu6r9aljim8su
14 Oct 16
IPO registration
12:00am
10-K
ic7 zsfe5970dbfbq
31 Mar 14
Annual report
12:00am
10-12G/A
gc8jmrlbz0wo38bs39
7 Feb 14
Registration of securities (amended)
12:00am
10-12G/A
yg934folmcufjuk4i
23 Jan 14
Registration of securities (amended)
12:00am
10-12G/A
0c2ybwijkmace cb
21 Nov 13
Registration of securities (amended)
12:00am